EUVIMEDEUVIMED entdecken
Crossref

Augmenting breast cancer diagnosis: Incorporating MRI for the assessment of major molecular subtypes

Meghana Meghavath, Rajani Gorantla, Ankamma Rao Danaboyina

Indian Journal of Breast Imaging · 2023

DOI: 10.25259/ijbi_10_2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Breast Imaging, 2023. Verfasst von Meghana Meghavath und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives: Breast cancer (BC) is one of the commonly encountered cancer in women around the world. It is a diverse medical disorder with multiple molecular subtypes that respond differently to therapy and have different prognoses. Subjects with the same stage of cancer and identical histological findings, on the other hand, can have disparities in clinical features and prognosis. Luminal A, Luminal B, Human epidermal growth factor receptor 2 (HER2) enriched, and triple-negative molecular subtypes were identified using novel technologies in expression analysis with DNA microarray. The precise identification of these subtypes is crucial for tailoring appropriate treatment strategies and improving patient outcomes. Dynamic contrast-enhanced magnetic resonance imaging (DCEMRI) is an excellent imaging technique for determining the extent of disease in BC patients prior to surgery. DECMRI with gadolinium-based contrasts is now the most sensitive identification tool for diagnosis, and it can be used in conjunction with mammography and ultrasound (USG). It aids in the detection of lesions that are not visible using other approaches. Material and Methods: Cross-sectional, observational study done over a period of 1 year. Sample size: 50 Inclusion criteria: Patients with morphological features of Breast Imaging Reporting and Data System (BI-RADS) 4b,4c,5 on USG or mammogram. Patients with malignancy confirmed through biopsy - BI-RADS 6. Patients aged above 18 years. Patients who provided informed consent to participate in the study. Exclusion criteria: Pregnant and lactating women. Patients with pacemakers, prosthetic heart valves, cochlear implants, or any metallic implants. Patients having a history of claustrophobia. Patients with prior surgery in the breast, hormonal therapy, radiation, or chemotherapy. Patients with previous allergic or anaphylactoid reactions to a gadolinium-based contrast. Patients with altered renal function test and estimated glomerular filtration rate

Zitieren

APA

Meghavath, M., Gorantla, R., & Danaboyina, A. R. (2023). Augmenting breast cancer diagnosis: Incorporating MRI for the assessment of major molecular subtypes. Indian Journal of Breast Imaging. https://doi.org/10.25259/ijbi_10_2023

Vancouver

Meghavath M, Gorantla R, Danaboyina AR. Augmenting breast cancer diagnosis: Incorporating MRI for the assessment of major molecular subtypes. Indian Journal of Breast Imaging. 2023. doi:10.25259/ijbi_10_2023

BibTeX
@article{Meghavath2023,
  author = {Meghavath, Meghana and Gorantla, Rajani and Danaboyina, Ankamma Rao},
  title = {Augmenting breast cancer diagnosis: Incorporating MRI for the assessment of major molecular subtypes},
  journal = {Indian Journal of Breast Imaging},
  year = {2023},
  doi = {10.25259/ijbi_10_2023}
}
Kostenlos starten →